PRKAB1 — Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1

PRKAB1 — Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1[@jeon2016]

Gene Overview

PRKAB1 — Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1[@jeon2016]

Gene Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PRKAB1 — Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PRKAB1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12q24.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[5564](https://www.ncbi.nlm.nih.gov/gene/5564)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[602636](https://www.omim.org/entry/602636)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000111725](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000111725)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9Y478](https://www.uniprot.org/uniprot/Q9Y478)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>270 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~30 kDa</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">PRKAA1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">PRKAA2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">PRKAG1/2/3</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">LKB1 (STK11)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">mTORC1</td>
<td>Indirect inhibition</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Direct phosphorylation</td>
</tr>
<tr>
<td class="label">PGC-1alpha</td>
<td>Indirect activation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/obesity" style="color:#ef9a9a">Obesity</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">27 edges</a></td>
</tr>
</table>

PRKAB1 (Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1) encodes the beta-1 regulatory subunit of AMP-activated protein kinase (AMPK). AMPK is a central cellular energy sensor that plays a critical role in regulating energy homeostasis across all eukaryotic cells. In the brain, AMPK regulates neuronal energy metabolism, mitochondrial function, [autophagy](/mechanisms/autophagy), protein quality control, and synaptic plasticity. Dysregulation of AMPK signaling has been strongly implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making PRKAB1 an important gene in understanding neurodegeneration mechanisms.

Basic Gene Information

Structure and Function

AMPK Heterotrimeric Complex

AMPK exists as a heterotrimeric complex composed of:

• Contains the kinase domain at the N-terminus
• Has an autoinhibitory domain (AID) that regulates activity
• Contains multiple phosphorylation sites (Thr172 is critical for activation)

• Provides structural support for the complex
• Contains a glycogen-binding domain (GBD)
• Facilitates subcellular localization
• PRKAB1 (beta-1) is the predominant isoform in most tissues

• Contains CBS domains that bind AMP/ADP and ATP
• Acts as the energy sensor within the complex
• Allosterically regulates AMPK activity

Beta-1 Subunit Specific Functions

The PRKAB1-encoded beta-1 subunit has distinct properties:

• The beta subunit contains a conserved carbohydrate-binding module
• This allows AMPK to sense cellular glycogen levels
• Modulates AMPK activity based on glycogen stores

• Provides structural stability to the heterotrimer
• Facilitates proper assembly of the alpha and gamma subunits
• Enables interaction with regulatory proteins

• PRKAB1 is the predominant beta isoform in most tissues including brain
• Higher expression in skeletal muscle and heart
• Alternative splicing generates tissue-specific isoforms

AMPK Activation Mechanism

AMPK is activated by cellular energy stress through multiple mechanisms:

Direct Activation by AMP/ADP

• When ATP levels fall and ADP/AMP rise, these nucleotides bind to the gamma subunit
• Binding induces conformational changes that:
• Promote phosphorylation of Thr172 on the alpha subunit
• Inhibit dephosphorylation of Thr172
• Allosterically enhance kinase activity

Allosteric Regulation

• AMP binding causes ~100-fold increase in activity
• ADP binding provides additional activation
• ATP acts as an inhibitor, overriding AMP/ADP effects

Upstream Kinases

• LKB1 (STK11) is the primary upstream kinase that phosphorylates AMPK
• CaMKKbeta can also phosphorylate AMPK in response to calcium signals
• Multiple phosphorylation sites fine-tune AMPK activity

Normal Physiological Functions

Energy Homeostasis

AMPK serves as the cell's energy thermostat:

ATP Production Activation

• Activates catabolic pathways that generate ATP
• Stimulates glycolysis by increasing glucose transporter (GLUT4) translocation
• Enhances fatty acid oxidation in mitochondria
• Activates autophagy to provide cellular building blocks

ATP Consumption Inhibition

• Inhibits anabolic pathways that consume ATP
• Blocks protein synthesis via mTORC1 inhibition
• Inhibits glycogen synthesis
• Suppresses fatty acid synthesis

Metabolic Regulation

Glucose Metabolism

• Enhances insulin sensitivity
• Promotes glucose uptake in muscle and brain
• Modulates gluconeogenesis in liver
• Regulates glycolytic enzyme activity

Lipid Metabolism

• Stimulates fatty acid oxidation
• Inhibits lipogenesis
• Regulates cholesterol synthesis
• Modulates triglyceride metabolism

Brain-Specific Functions

Neuronal Energy Management

• Coordinates glucose metabolism in neurons
• Manages astrocyte-neuron metabolic coupling
• Responds to neuronal activity-driven energy demands
• Protects against metabolic stress

Mitochondrial Function

• Promotes mitochondrial biogenesis via PGC-1alpha activation
• Maintains mitochondrial quality control
• Regulates mitochondrial dynamics (fusion/fission)
• Supports mitochondrial DNA repair

Autophagy Regulation

• Activates autophagy through mTORC1 inhibition
• Coordinates removal of damaged proteins
• Facilitates clearance of protein aggregates
• Supports organelle turnover

Role in Neurodegenerative Diseases

Alzheimer's Disease

AMPK dysregulation plays complex roles in Alzheimer's disease pathogenesis:

Amyloid-Beta Metabolism

• AMPK activation can reduce amyloid-beta production through:
• Inhibition of BACE1 (beta-secretase) activity
• Modulation of amyloid precursor protein (APP) processing
• Enhanced amyloid-beta clearance via autophagy
• However, chronic AMPK overactivation may:
• Disrupt neuronal energy balance
• Impair synaptic function
• Contribute to tau pathology

Tau Pathology

• AMPK can phosphorylate tau at multiple sites
• This may promote tau aggregation or clearance depending on context
• AMPK-mediated tau phosphorylation contributes to neurofibrillary tangle formation

Mitochondrial Dysfunction

• AMPK signaling is impaired in AD brain
• Reduced AMPK activity contributes to:
• Decreased mitochondrial biogenesis
• Impaired mitochondrial quality control
• Energy deficits in neurons

Neuroinflammation

• AMPK has anti-inflammatory properties
• Its activation can:
• Reduce microglial activation
• Suppress pro-inflammatory cytokine production
• Modulate neuroinflammatory responses

Synaptic Dysfunction

• AMPK is involved in synaptic plasticity
• Altered AMPK signaling contributes to:
• Impaired long-term potentiation (LTP)
• Synaptic energy deficits
• Memory dysfunction

Parkinson's Disease

AMPK activation has neuroprotective effects in PD:

Alpha-Synuclein Metabolism

• AMPK activation enhances autophagy-mediated clearance of alpha-synuclein
• This reduces intracellular protein aggregate accumulation
• May protect dopaminergic neurons from toxic species

Mitochondrial Protection

• AMPK promotes mitochondrial biogenesis via PGC-1alpha
• Protects against mitochondrial toxins (e.g., MPTP, 6-OHDA)
• Maintains dopaminergic neuron survival

Energy Metabolism

• PD is associated with energy deficits in dopaminergic neurons
• AMPK activation helps restore energy balance
• Improves neuronal resilience to metabolic stress

Neuroinflammation

• AMPK activation reduces neuroinflammation
• Protects against inflammatory dopaminergic degeneration

Other Neurodegenerative Conditions

Huntington's Disease

• AMPK is hyperactivated in HD models
• Contributes to neuronal dysfunction
• Modulating AMPK may offer therapeutic benefit

Amyotrophic Lateral Sclerosis (ALS)

• AMPK signaling is altered in ALS
• Energy deficits contribute to motor neuron degeneration
• AMPK modulators are being explored

Stroke and Brain Ischemia

• AMPK is activated by ischemic stress
• Has both protective and damaging effects
• Timing and context determine outcome

Signaling Pathways

mTORC1 Pathway

AMPK and mTORC1 represent opposing regulatory axes:

• AMPK inhibits mTORC1 through multiple mechanisms
• This coordinates growth with energy availability
• In neurodegeneration, this axis is often dysregulated

PGC-1alpha Signaling

AMPK activates mitochondrial biogenesis:

• Phosphorylates and activates PGC-1alpha
• Promotes expression of mitochondrial genes
• Maintains mitochondrial population

Autophagy Pathways

AMPK triggers autophagy through multiple routes:

• Direct mTORC1 inhibition
• Phosphorylation of ULK1 initiation complex
• Regulation of autophagy gene expression

Insulin Signaling

AMPK intersects with insulin pathways:

• Cross-talk with Akt signaling
• Modulates insulin sensitivity
• Coordinates metabolic responses

Expression Pattern in the Brain

Regional distribution shows high expression in:

• Hippocampus (CA1, CA3 regions)
• Cerebral cortex (layers 2-6)
• Cerebellum (Purkinje cells)
• Basal ganglia

Therapeutic Implications

AMPK Activators as Therapeutic Agents

Several classes of AMPK activators are being explored:

Direct Activators

• AICAR (5-aminoimidazole-4-carboxamide ribonucleoside)
• Metabolized to ZMP, mimics AMP
• Limited by side effects and bioavailability
• A-769662
• Allosteric activator
• Better specificity than AICAR

Indirect Activators

• Metformin
• Activates AMPK via mitochondrial respiratory chain inhibition
• Widely used for type 2 diabetes
• Being investigated for neurodegeneration
• Resveratrol
• Polyphenol with AMPK-activating properties
• Shown to improve cognition in some studies
• Berberine
• Natural alkaloid with AMPK activity
• Being studied in AD models

Challenges in Targeting AMPK

• Achieving brain penetration
• Balancing activation vs. overactivation
• Timing of intervention
• Cell-type specificity

Interaction Network

Protein-Protein Interactions

Downstream Targets

AMPK phosphorylates numerous substrates:

• Metabolic enzymes: ACC, TBC1D1
• Transcription factors: PGC-1alpha, FoxO
• Translational regulators: TSC2, Raptor
• Autophagy proteins: ULK1, Beclin-1

Research Methods

Studying AMPK in Neurodegeneration

Key experimental approaches:

See Also

• [AMPK Complex](/mechanisms/ampk-signaling) - Overview of AMPK signaling
• [Autophagy Mechanisms](/mechanisms/autophagy) - AMPK-regulated process
• [Mitochondrial Biogenesis](/mechanisms/mitochondrial-biogenesis) - PGC-1alpha pathway
• [mTOR Signaling](/mechanisms/mtor-signaling) - AMPK-opposed pathway
• [Energy Metabolism](/mechanisms/cellular-energy-metabolism) - Brain energy homeostasis

External Links

• [NCBI Gene: PRKAB1](https://www.ncbi.nlm.nih.gov/gene/5564)
• [UniProt: Q9Y478](https://www.uniprot.org/uniprot/Q9Y478)
• [Ensembl: ENSG00000111725](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000111725)
• [PubMed: AMPK neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=AMPK+neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving PRKAB1 — Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1 discovered through SciDEX knowledge graph analysis:

Disease Associations

Source: Open Targets Platform (opentargets.org)

| Disease | Association Score | Disease ID |
|--------|-------------------|------------|
| neurodegenerative disease | 0.4773 | EFO_0005772 |
| inflammatory bowel disease | 0.3846 | EFO_0003767 |
| cardiovascular disease | 0.3791 | EFO_0000319 |
| Alzheimer disease | 0.3720 | MONDO_0004975 |
| Parkinson disease | 0.3600 | MONDO_0005180 |